SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5FC4E39DC1D1E766E0A644448D19A77DF8805D0A92428DB1115F35840361F726485C936E2A322BB8C0C18A7A042E518D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5FC4E39DC1D1E766E0A644448D19A77DF8805D0A92428DB1115F35840361F726485C936E2A322BB8C0C18A7A042E518D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5FC4E39DC1D1E766E0A644448D19A77DF8805D0A92428DB1115F35840361F726485C936E2A322BB8C0C18A7A042E518D
http://www.w3.org/2000/01/rdf-schema#comment
"These data demonstrate that LB-100 is a catalytic inhibitor of both PP2AC and PPP5C and suggest that the observed antitumor activity might be due to an additive effect achieved by suppressing both PP2A and PPP5C."
xsd:string
http://purl.uniprot.org/uniprot/#_32F3A051D1E030CFCFFCE324763805D6EBB4E35F4C3164D568C846ABC7C03E7CFBA71EE4EE69DDD9BE725A66A286DCE6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5FC4E39DC1D1E766E0A644448D19A77DF8805D0A92428DB1115F35840361F726485C936E2A322BB8C0C18A7A042E518D
http://purl.uniprot.org/uniprot/P53041
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5FC4E39DC1D1E766E0A644448D19A77DF8805D0A92428DB1115F35840361F726485C936E2A322BB8C0C18A7A042E518D
http://purl.uniprot.org/uniprot/#_P53041-mappedCitation-30679389
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5FC4E39DC1D1E766E0A644448D19A77DF8805D0A92428DB1115F35840361F726485C936E2A322BB8C0C18A7A042E518D